The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.
about
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsLithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cellsEffects of NSAIDs on the risk factors of colorectal cancer: a mini reviewFortifying the Treatment of Prostate Cancer with Physical ActivityThe balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesisThe association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsInsulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskAlterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metforminMetformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cellsResponse of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combinedThe LKB1-AMPK pathway: metabolism and growth control in tumour suppression2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsMetformin effects on biochemical recurrence and metabolic signaling in the prostate.Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.Latest insights into the risk of cancer in diabetesAdiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activationIncidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathwaysA 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survivalPhysical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavorGlycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.Functional effects of a pathogenic mutation in Cereblon (CRBN) on the regulation of protein synthesis via the AMPK-mTOR cascade.Metformin and cancer.Metformin and other biguanides in oncology: advancing the research agenda.Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.The role of adiponectin in cancer: a review of current evidence.Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.The complexities of obesity and diabetes with the development and progression of pancreatic cancer.New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKMetabolic alterations and targeted therapies in prostate cancer.Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway.Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolismNo evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
P2860
Q22242884-19E81123-A4E2-4F17-BC27-779A7F2E7809Q24617423-6CA3BD3F-DCFA-4130-985D-38361D010405Q26746884-042CA0E6-307A-4679-A623-C54C2AA8942DQ26765503-CAB2C51D-BD79-4F0F-A243-D07E28936667Q26830203-C2E0DF71-73A7-4DE2-A32C-412CAFF475CAQ27026813-122416C6-36BB-415A-816A-33F1EF511275Q28072521-19B5247A-58CE-4FD5-9054-A1FACDAF59A2Q28485299-3C49EFE8-8224-49D3-8950-70CCCFCB46FFQ28539104-8288E9B2-7828-49CC-A64D-7BE105A35A15Q28539523-4B4FE825-1ED2-43C4-B30D-17041F12ECAFQ29617506-918A7F4B-E667-4397-9E07-5141334393ECQ30239808-79AA3218-F6E6-453A-AB4A-DEA2C4682CE9Q30665188-4A9EADBE-3EA1-4D6D-BD74-A75B86A0387BQ31115487-FD224113-DC1B-4130-BBD0-99EE809061FFQ33588852-A0CF2FE3-0799-4646-A641-AD82BD50C23FQ33637485-3062533A-255B-4F5F-B7F7-A67924A0A6D7Q33793812-D3E31D7C-C06D-4200-8FE0-8338F50F6DA4Q33800268-7D4AB0D5-E2C7-4120-BD0F-39A5720732E4Q33806363-272927EC-415E-40A5-A292-105D7FF4E7BFQ33910774-877DBFBB-E2E1-4022-97F3-C0F7E1377B4AQ33935606-4D07857C-2ABC-4004-9286-31954AAE563FQ34040946-2AF10BAF-4435-4D32-8DD6-2B8357DAA797Q34131778-FC6B28AC-4F30-4DD2-8BDE-2F984F14C6A6Q34141068-A330CBCD-AB2F-4ECB-957F-8CEB9198FBF0Q34159241-8651FF6D-A0C0-4D83-9B0E-D03449661E73Q34196114-F4FEF326-CC93-4FAC-B061-367689A03656Q34250109-D46F696F-3388-4CE7-BB49-B5476CCB96DDQ34271986-E364AAF6-0388-4F1B-B2C6-851C02335A5FQ34438700-A8E7CAEE-FBBE-4AEF-9AED-0D76E6A404C9Q34669361-C3676CA8-2276-46CC-B812-413F5856A038Q35222084-80090CD9-97E0-4D06-A789-4BC6122BFA00Q35401667-E35C665A-0F26-4C18-957D-7A8989C75E05Q35612112-1C09B9D7-FF02-475D-991A-F40CF8B918BAQ35702142-90C03E99-5DB7-4B17-B86B-16EA2189D879Q35801392-26164D22-20C1-402D-89A6-7E9943759BF2Q35810943-AE68060C-AA88-425C-8932-281BF7C6AA79Q35842470-064D4DEA-9600-4652-8927-25519A9F7171Q35858819-2B1BDF5C-3FB1-43C6-890F-0C3DC4549EA1Q35865232-346D2BA1-FDA8-43F5-BD94-7CE16697B476Q35877999-D984C804-FAC5-487C-B489-C6AB38FCF126
P2860
The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The effects of adiponectin and ...... AMP-activated protein kinase.
@en
The effects of adiponectin and ...... AMP-activated protein kinase.
@nl
type
label
The effects of adiponectin and ...... AMP-activated protein kinase.
@en
The effects of adiponectin and ...... AMP-activated protein kinase.
@nl
prefLabel
The effects of adiponectin and ...... AMP-activated protein kinase.
@en
The effects of adiponectin and ...... AMP-activated protein kinase.
@nl
P2093
P1476
The effects of adiponectin and ...... AMP-activated protein kinase.
@en
P2093
Mahvash Zakikhani
Michael N Pollak
Ryan J O Dowling
P304
P356
10.1158/1940-6207.CAPR-08-0081
P577
2008-10-01T00:00:00Z